grey glp-1 Study Finds GLP-1s Are Effectively Over-the-Counter Drugs in Online Market GLP-1s: What They Are and

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

These tests could include ultrasound, elastography, MRI, CT, or 18FDG-PET scans

And sometimes the body simply needs time to adjust to its new metabolic setpoint before continuing to lose fat

Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP Founder, Functional Medicine University Medical & Educational Disclaimer : The information provided is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment